G6PD gene mutations in India producing drug-induced haemolytic anaemia

British Journal of Haematology

Volumn 116, Issue 3, 2002, Pages 671-672

  Sukumar, Sridevi ^a   Colah, Roshan ^a   Mohanty, Dipika ^a  

^a KEM HOSPITAL   (India)

Author keywords

Drugs; G6PD deficiency; Haemolytic anaemia; India; Mutations

Indexed keywords

AMPICILLIN; ANTIMALARIAL AGENT; CAFFEINE; CHLOROQUINE; CHLORPHENIRAMINE MALEATE; CIPROFLOXACIN; MEBHYDROLIN NAPADISILATE; MEFLOQUINE; PARACETAMOL; PRIMAQUINE; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; GENE MUTATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INDIA; MALARIA; MALE; PRIORITY JOURNAL; TRANSFUSION;

ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC; ANTIMALARIALS; CHILD; FOLLOW-UP STUDIES; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALE; MUTATION;

EID: 0036182620     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2001.03328.x     Document Type: Article

References (4)

1. The genetics of glucose-6-phosphate dehydrogenase deficiency
2. G6PD deficiency
3. Mediterranean type of G6PD deficiency in Bengalees
4. A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala → Gly), is the major polymorphic variant in tribal populations in India